An observational study in Uncontrolled Hypertension, sponsored by Ankara University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-27.
Sponsored by Ankara University · Observational
Hypertension is an underdiagnosed and undertreated disease in real-life. Blood pressure and kidney functions are known to be closely related. Increased serum level of Cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. The investigators aimed to evaluate the predictive value of serum Cystatin C for control of hypertension in a community-based study.
6,834 studies on the registry are indexed under Hypertension; 971 are open to participants now.
This study's enrollment of 903 is above the median of 210 across 1,392 observational studies indexed under Hypertension.
Browse Hypertension studies →Ankara University is the lead sponsor of 318 studies on the registry; 65 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Adults residing in both rural and urban communities
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The prevalence of uncontrolled hypertension
The outcome measures will be obtained at the time of enrollment
Time frame: At subject enrollment
The value of cystatin C to determine uncontrolled hypertension
The outcome measures will be obtained at the time of enrollment
Time frame: At subject enrollment
The record gives a start of Jan 2014, a primary completion of Jan 2015 and a completion of Jan 2015. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.